Abstract

Objectives: Attendees will learn how to identify appropriate chronic migraine candidates for onabotulinumtoxinA therapy, master safe and effective injection techniques, and apply evidence-based dosing protocols. They will also recognize potential adverse effects, integrate patient monitoring strategies, and ultimately enhance symptom management and quality of life. Introduction: Chronic migraine can severely impact daily functioning. Evidence shows that Botulinum toxin injections significantly reduce headache frequency and severity. This presentation outlines the pathophysiology underpinning botulinum toxin’s efficacy, reviews key clinical trial data, and highlights critical steps for successful treatment outcomes through a video session. Materials / method: Data were gathered from peer-reviewed studies, clinical practice guidelines, and Dr. Treacy’s extensive experience. The PREEMPT protocol will be explained, including detailed injection sites, dosing intervals, and follow-up assessments. Emphasis is placed on patient selection criteria, injection technique, and strategies to minimize adverse effects. Results: Observed outcomes include a marked reduction in monthly headache days, decreased reliance on rescue medications, and improved patient-reported quality of life. Adverse effects were minimal and transient. These findings corroborate existing literature, reinforcing onabotulinumtoxinA’s role as a well-tolerated, effective prophylactic treatment. Conclusion: Botulinum toxin injections offer a safe, efficacious option for chronic migraine prophylaxis. Mastery of proper technique, patient assessment, and diligent follow-up is essential for optimal results. With continued research and practitioner education, Botox therapy can significantly enhance outcomes and quality of life for migraine patients.